Becker's Healthcare May 24, 2024
Mariah Taylor

FDA advisers have recommended the approval of Guardant Health’s blood test to detect colon or rectal cancers — but it also raised some concerns, NBC News reported May 23.

The panel voted 7-2 in favor of approving Gaurdant’s test, Shield. If the FDA does approve it, it will be the second blood-based test for colon cancer, competing with Epigenomics’ Epi proColon, which was approved in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Medical Devices, Patient / Consumer, Provider
Opinion: RFK Jr. and MAHA should champion a Marshall Plan for obesity
Will Trump's healthcare appointments bring 'radical changes'?
BridgeBio poised to challenge Pfizer after Attruby approval
STAT+: Trump’s FDA director pick has a history of criticizing the agency. Here are seven examples
Trump names nominees to lead CDC, FDA, and his pick for surgeon general

Share This Article